VRCA Q3 2022 Earnings — Verrica Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

VRCAVerrica Pharmaceuticals Inc.

$57M

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M

Gross Profit

$8M98.0% margin

Operating Income

$1M17.4% margin

Net Income

$83,0001.0% margin

EPS (Diluted)

$0.02

QoQ Revenue Growth

+3787.4%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$2M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$49M

Total Liabilities

$4M

Stockholders' Equity

$45M

Cash & Equivalents

$32M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$0	—
Gross Profit	$8M	-$111,000	+7445.0%
Operating Income	$1M	-$12M	+112.3%
Net Income	$83,000	-$13M	+100.6%